Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020

Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020

We determined the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an affected area in northern Iran in April 2020. Antibodies to SARS-CoV-2 were detected in 528 persons by using rapid tests. Adjusted prevalence of SARS-CoV-2 seropositivity was 22.2% (95% CI 16.4%–2...

Full description

Bibliographic Details
Main Authors: Maryam Shakiba, Maryam Nazemipour, Arsalan Salari, Fardin Mehrabian, Seyed Saeed H. Nazari, Seyed Mahmoud Rezvani, Zahra Ghasempour, Abtin Heidarzadeh, Mohammad Ali Mansournia
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2021-02-01
Series:Emerging Infectious Diseases
Subjects:
asymptomatic infections
COVID-19
seroprevalence
coronavirus disease
SARS-CoV-2
severe acute respiratory syndrome coronavirus 2
Online Access:https://wwwnc.cdc.gov/eid/article/27/2/20-1960_article
Description
Summary:We determined the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an affected area in northern Iran in April 2020. Antibodies to SARS-CoV-2 were detected in 528 persons by using rapid tests. Adjusted prevalence of SARS-CoV-2 seropositivity was 22.2% (95% CI 16.4%–28.5%).
ISSN:1080-6040
1080-6059

Similar Items